Drug Trial Radar · NCT00368108
Efficacy, Safety, and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations
Last checked: Nov 20, 2026Latest source record: May 20, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
752
Actual
Start
Aug 2006
Primary completion
Jan 2008
Study completion Jan 2008
Sponsor
- Lead sponsor
- Eisai Inc.Eisai
- Sponsor type
- Industry
- First posted
- Aug 24, 2006
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 30 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multi-center, randomized, double-blind, placebo-controlled, parallel-group study of E2007 in levodopa treated Parkinson's disease patients with motor fluctuations.
Conditions
- Parkinson's Disease
Interventions
2 mg perampanelDrug
2 mg perampanel
4 mg perampanelDrug
4 mg perampanel
placebo comparatorDrug
placebo comparator
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Change From Baseline in Total Daily OFF Time (Hours) to Week 20 (Including Last Observation Carried Forward [LOCF] Data)Time frame: Baseline and Week 20
Locations
114 sites in 2 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
North Alabama Neuroscience Research Associates
Huntsville, Alabama
Pivotal Research Centers
Peoria, Arizona
Mayo Clinic Arizona
Scottsdale, Arizona
Northwest NeuroSpecialists, PLLC
Tucson, Arizona
Clinical Trials Inc.
Little Rock, Arkansas
UAMS Department of Neurology
Little Rock, Arkansas
The Parkinson's and Movement Disorder Institute
Fountain Valley, California
Margolin Brain Institute
Fresno, California
University of California Medical Center - Irvine
Irvine, California
Coastal Neurological Group
La Jolla, California
Scripps Clinic
La Jolla, California
University of California at San Diego - Department of Neurology
La Jolla, California
Loma Linda University
Loma Linda, California
University of Southern California
Los Angeles, California
Pacific Neuroscience Medical Group, Inc.
Oxnard, California
University of California San Francisco Medical Center
San Francisco, California
The Parkinson's Institute
Sunnyvale, California
Mile High Research Center
Denver, Colorado
University Of Colorado
Denver, Colorado
Colorado Neurology
Englewood, Colorado
Associated Neurologists, PC - Danbury
Danbury, Connecticut
Hartford Hospital
Hartford, Connecticut
Molecular Neuroimaging, LLC
New Haven, Connecticut
Georgetown University Hospital
Washington D.C., District of Columbia
Parkinson's Disease and Movement Disorder Center of Boca Raton
Boca Raton, Florida
Brain Matters Research
Delray Beach, Florida
University of Florida
Gainesville, Florida
Sunrise Clinical Research
Hollywood, Florida
University of Florida - Department of Neurology
Jacksonville, Florida
Mayo Clinic Jacksonville
Jacksonville, Florida
University of Miami
Miami, Florida
Miami Research Associates
Miami, Florida
Palm Beach Neurological Center
Palm Beach Gardens, Florida
Gil, Ramon A.
Port Charlotte, Florida
Suncoast Neuroscience Associates, Inc.
St. Petersburg, Florida
University Of South Florida Movement Disorders Clinic
Tampa, Florida
Cleveland Clinic Florida - Weston
Weston, Florida
Emory University
Atlanta, Georgia
Medical College of Georgia
Augusta, Georgia
Showing 40 of 114 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.